Mr. Ricardo S Pineda, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 900 S Atlantic Blvd, Monterey Park, CA 91754 Phone: 626-570-9000 |
Reena Vasquez, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 900 S Atlantic Blvd, Monterey Park, CA 91754 Phone: 626-570-9000 |
Marvin James Lopez Barruga, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 850 S Atlantic Blvd Ste 201, Monterey Park, CA 91754 Phone: 909-570-9108 Fax: 909-570-9334 |
Ms. Idena Davidson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 900 S Atlantic Blvd, Monterey Park, CA 91754 Phone: 626-570-9000 Fax: 626-570-5700 |
Brian William Burney, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 850s Atlantic Blvd 201, Monterey Park, CA 91754 Phone: 626-289-2894 Fax: 951-296-6741 |
News Archive
A new study has demonstrated that using the 'wisdom of crowds' (also known as collective intelligence) of three or more medical prescribers, can improve decisions about antibiotic prescribing and help combat rising levels of antibiotic resistance.
Momentum appears to building for efforts to address record budget deficits by reining in spending on Social Security, Medicare and Medicaid. Meanwhile, as both parties agree they need to reach a deal to provide funding to keep the government functioning in the the current year, legislative riders that would impose restrictions on federal agencies and cut off funding for Planned Parenthood continue to trip up their progress.
Researchers at the University of Southampton have engineered cells with a 'built-in genetic circuit' that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
Industry-funded clinical trials of breast cancer medications report more favorable results than nonindustry supported research, according to a study published in the Feb. 26 online edition of the journal Cancer, the New York Times reports (Bakalar, New York Times, 2/27).
Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.
› Verified 6 days ago